From Tumor Mutational Burden to Blood T Cell Receptor: Looking for the Best Predictive Biomarker in Lung Cancer Treated with Immunotherapy
Simple Summary
Sesma, A.; Pardo, J.; Cruellas, M.; Gálvez, E.M.; Gascón, M.; Isla, D.; Martínez-Lostao, L.; Ocáriz, M.; Paño, J.R.; Quílez, E.; Ramírez, A.; Torres-Ramón, I.; Yubero, A.; Zapata, M.; Lastra, R. From Tumor Mutational Burden to Blood T Cell Receptor: Looking for the Best Predictive Biomarker in Lung Cancer Treated with Immunotherapy. Cancers 2020, 12, 2974.
Sesma A, Pardo J, Cruellas M, Gálvez EM, Gascón M, Isla D, Martínez-Lostao L, Ocáriz M, Paño JR, Quílez E, Ramírez A, Torres-Ramón I, Yubero A, Zapata M, Lastra R. From Tumor Mutational Burden to Blood T Cell Receptor: Looking for the Best Predictive Biomarker in Lung Cancer Treated with Immunotherapy. Cancers. 2020; 12(10):2974.
Chicago/Turabian StyleSesma, Andrea; Pardo, Julián; Cruellas, Mara; Gálvez, Eva M.; Gascón, Marta; Isla, Dolores; Martínez-Lostao, Luis; Ocáriz, Maitane; Paño, José R.; Quílez, Elisa; Ramírez, Ariel; Torres-Ramón, Irene; Yubero, Alfonso; Zapata, María; Lastra, Rodrigo. 2020. "From Tumor Mutational Burden to Blood T Cell Receptor: Looking for the Best Predictive Biomarker in Lung Cancer Treated with Immunotherapy" Cancers 12, no. 10: 2974.